.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A recent ecological study suggests that breastfeeding and long-term immunity are closely linked. Researchers analyzed data from 159 counties in Georgia over a two-year period during the COVID-19 pandemic. Consequently, they found that communities with higher breastfeeding rates experienced a significantly lower burden of the disease. Specifically, the study compared counties with low breastfeeding initiation rates to those with higher rates. The results showed a clear correlation between nursing practices and reduced viral impact across entire populations.
The research indicates that maternal antibodies may offer protection far beyond the neonatal period. Counties with high breastfeeding rates saw an incidence rate ratio of 0.83 compared to low-rate counties. Furthermore, the mortality rate ratio was even lower at 0.75. This suggests that breastfeeding might help program the immune system for years. In contrast, counties with lower nursing rates struggled with higher fatality rates of 0.88. Therefore, clinical experts believe that maternal cellular immunity plays a vital role in long-term public health. Moreover, these findings underscore the importance of supporting maternal health to combat emerging infectious diseases.
Additionally, the study adjusted for several factors like poverty and healthcare access. Even after these adjustments, the protective effect remained statistically significant. In addition, the findings align with animal studies showing maternal transfer of cellular immunity. However, more individual-level research is necessary to confirm these broad ecological trends. Ultimately, this evidence supports national programs that promote breastfeeding as a foundational health intervention. Consequently, doctors should continue to advocate for exclusive breastfeeding to improve community resilience against future pandemics.
This study looked at county-level data, showing that communities with high breastfeeding rates had lower COVID-19 mortality. This suggests that breastfeeding may confer long-term immunity that persists as the child grows into an adult.
Breast milk contains secretory IgA, IgG, and specialized immune cells. These components help train the infant\'s immune system to recognize and fight off emerging infectious pathogens more effectively throughout life.
Yes, the biological mechanisms of maternal immunity are universal. Promoting breastfeeding in India can help build long-term immunity against various respiratory and infectious diseases within the population.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Chopak-Foss J et al. Breastfeeding May Confer Long-Term Immunity Against Emerging Infectious Pathogens-Ecological Evidence over 2 Full Years of the COVID-19 Epidemic in Georgia, United States. Breastfeed Med. 2026 May 23. doi: 10.1177/15568253261450169. PMID: 42175749.
Valcarce V et al. Persistence of COVID-19 Human Milk Antibodies After Maternal COVID-19 Vaccination. Frontiers in Nutrition. 2024.
World Health Organization. Breastfeeding and COVID-19: Scientific Brief. 2020.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A 2-year study in Georgia, USA, reveals that counties with higher breastfeeding rates had significantly lower COVID-19 incidence, mortality, and fatality ra...
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
